Herpes zoster mRNA vaccine (Shanghai Institute Of Biological/Rongcan Biomedical)
带状疱疹mRNA疫苗（上海生物制品/荣灿生物）
Report date: 2026/04/03 20:03:44
Base Information
Drug NameHerpes zoster mRNA vaccine (Shanghai Institute Of Biological/Rongcan Biomedical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Institute of Biological Products Co LtdRongcan Biomedical Technology (Shanghai) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesRongcan Biomedical Technology (Shanghai) Co LtdShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A